Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Phase 1 study of trimethylpurin-6-ylammonium chloride (NSC-51095).

Phase 1 study of trimethylpurin-6-ylammonium chloride (NSC-51095). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Phase 1 study of trimethylpurin-6-ylammonium chloride (NSC-51095). Abstract Text:

    r w phillipsR W Phillips,

    Phase 1 study of trimethylpurin-6-ylammonium chloride (NSC-51095). Publishing Authors By Initials

    rw phillipsRW Phillips,

    For similar heterocyclic compounds: heterocyclic compounds, 2-ring: purines research abstracts see: heterocyclic compounds: heterocyclic compounds, 2-ring: purines research

    PUBMED ID PMID:

    MEDLINE DATE:

    Phase 1 study of trimethylpurin-6-ylammonium chloride (NSC-51095). Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Cancer chemotherapy reports. Part 1

    VOLUME: 52

    Page Numbers: 417-22

    Journal Abbreviation:

    ISSN: 0069-0112

    DAY: 20

    MONTH: Apr

    YEAR: 1968

    Phase 1 study of trimethylpurin-6-ylammonium chloride (NSC-51095). Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7607105

    Phase 1 study of trimethylpurin-6-ylammonium chloride (NSC-51095). Keywords Mesh Terms:

    KEYWORDS: Purines

    MESH TERMS: therapeutic use

    Chemical & Substance for Abstract: Phase 1 study of trimethylpurin-6-ylammonium chloride (NSC-51095). Information

    Substance Name: Methane

    Registry Number: 74-82-8

    Grant and Affiliation Information for Phase 1 study of trimethylpurin-6-ylammonium chloride (NSC-51095).

    AFFILIATION:

    Country: UNITED STATES

    UNITED STATES Research PublicationUNITED STATES Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Cancer Chemother Rep

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Phase 1 study of trimethylpurin-6-ylammonium chloride NSC-51095 Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News